178 related articles for article (PubMed ID: 29861866)
1. TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma.
Moriwaki K; Ayani Y; Kuwabara H; Terada T; Kawata R; Asahi M
Oncotarget; 2018 May; 9(38):25225-25243. PubMed ID: 29861866
[TBL] [Abstract][Full Text] [Related]
2. Oral squamous cell carcinoma-released brain-derived neurotrophic factor contributes to oral cancer pain by peripheral tropomyosin receptor kinase B activation.
Grayson M; Arris D; Wu P; Merlo J; Ibrahim T; Fang-Mei C; Valenzuela V; Ganatra S; Ruparel S
Pain; 2022 Mar; 163(3):496-507. PubMed ID: 34321412
[TBL] [Abstract][Full Text] [Related]
3. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
6. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
[TBL] [Abstract][Full Text] [Related]
7. BDNF/TRKB axis provokes EMT progression to induce cell aggressiveness via crosstalk with cancer-associated fibroblasts in human parotid gland cancer.
Moriwaki K; Wada M; Kuwabara H; Ayani Y; Terada T; Higashino M; Kawata R; Asahi M
Sci Rep; 2022 Oct; 12(1):17553. PubMed ID: 36266462
[TBL] [Abstract][Full Text] [Related]
8. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
Kawamura K; Kawamura N; Okamoto N; Manabe M
Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
[TBL] [Abstract][Full Text] [Related]
9. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.
Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M
Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550
[TBL] [Abstract][Full Text] [Related]
10. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
Jia S; Wang W; Hu Z; Shan C; Wang L; Wu B; Yang Z; Yang X; Lei D
Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007
[TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
[TBL] [Abstract][Full Text] [Related]
12. Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.
Akil H; Perraud A; Mélin C; Jauberteau MO; Mathonnet M
PLoS One; 2011; 6(9):e25097. PubMed ID: 21966426
[TBL] [Abstract][Full Text] [Related]
13. Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.
de Moraes JK; Wagner VP; Fonseca FP; Vargas PA; de Farias CB; Roesler R; Martins MD
J Oral Pathol Med; 2018 Mar; 47(3):221-227. PubMed ID: 28650560
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
15. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.
Lim JY; Park SI; Kim SM; Jun JA; Oh JH; Ryu CH; Jeong CH; Park SH; Park SA; Oh W; Chang JW; Jeun SS
Cell Transplant; 2011; 20(11-12):1855-66. PubMed ID: 21375801
[TBL] [Abstract][Full Text] [Related]
16. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
17. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.
Choy C; Ansari KI; Neman J; Hsu S; Duenas MJ; Li H; Vaidehi N; Jandial R
Breast Cancer Res; 2017 Apr; 19(1):51. PubMed ID: 28446206
[TBL] [Abstract][Full Text] [Related]
19. Expression of BDNF, TrkB, VEGF and CD105 is associated with pelvic lymph node metastasis and prognosis in IB2-stage squamous cell carcinoma.
Qi Y; Li W; Kang S; Chen L; Hao M; Wang W; Ling B; Cui Z; Liang C; He J; Chen X; Chen C; Liu P
Exp Ther Med; 2019 Dec; 18(6):4221-4230. PubMed ID: 31777532
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]